Sort
11,323 grants matching “glioblastoma”
Quantitative MR-PET for Therapy Assessment in Glioma Patients
$625,486Ciprian Catana · Massachusetts General Hospital · R01 · FY2011 · CA
A Systems Biology Platform for Integrative Cancer Biology Research
$625,485Yuri V. Nikolsky · Genego, Inc. · R44 · FY2010 · CA
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
$625,207Kim Butts Pauly · Stanford University · R01 · FY2020 · CA
Chemical tools for developmental biology
$625,036James K Chen · Stanford University · R35 · FY2023 · GM
Chemical tools for developmental biology
$625,036James K Chen · Stanford University · R35 · FY2024 · GM
Chemical tools for developmental biology
$625,036James K Chen · Stanford University · R35 · FY2025 · GM
Generalizable quantitative imaging and machine learning signatures in glioblastoma, for precision diagnostics and personalized treatment: the ReSPOND consortium
$624,867Christos Davatzikos · University Of Pennsylvania · R01 · FY2025 · CA
Dissect governing factors for tumor stem cell dormancy in biomimetic vascular/GBM model
$624,707Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · NS
Pre-clinical Development of Radiation Sensitizers for Patients with Glioblastoma
$624,662Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for Glioblastoma
$624,616Constantinos George Hadjipanayis · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$624,603William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Engineering T Cell Adoptive Therapy for Glioblastoma
$624,543Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2024 · NS
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA
$624,087Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2012 · CA
ROLE OF N-CADHERIN IN THE THERAPEUTIC RESISTANCE OF GLIOBLASTOMA
$624,000Emory University · · FY2018 · Department of the Army
Resource Core II: In Vivo Core
$623,888Piotr Hadaczek · University Of California Berkeley · U19 · FY2025 · NS
Therapeutic Targeting of Malignant Glioma Stem Cells
$623,888Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2015 · CA
Quantitative MRSI to predict early response to SAHA therapy in new GBM management
$623,858Hyunsuk Shim · Emory University · U01 · FY2016 · CA
MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
$623,825Max Wintermark · Stanford University · R01 · FY2020 · CA
Therapeutic targeting mesenchymal transition in newly diagnosed and recurrent GBM
$623,787Frank Furnari · University Of California, San Diego · R01 · FY2025 · NS
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$623,782Lance L Munn · Massachusetts General Hospital · U01 · FY2021 · CA
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$623,782Lance L Munn · Massachusetts General Hospital · U01 · FY2025 · CA
Gutless Adenovirus Mediated Gene Therapy for Glioma
$623,550Maria G Castro · Cedars-Sinai Medical Center · U01 · FY2010 · NS
Magnetofluorescent nanoplatform for glioblastoma therapy
$623,483John S Yu · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Enhanced Delivery of Cytotoxic Neural Stem Cells for Treatment of Glioblastoma Multiforme Using an Innovative In-situ Thermogelling Hydrogel and Focused Ultrasound
$623,467Soumya Rahima Benhabbour · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
The roles of p53 in embryonic stem cells
$623,372Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA